乳腺癌组织中低密度脂蛋白受体的含量与患者生存率的关系。
Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.
作者信息
Rudling M J, Ståhle L, Peterson C O, Skoog L
出版信息
Br Med J (Clin Res Ed). 1986 Mar 1;292(6520):580-2. doi: 10.1136/bmj.292.6520.580.
Abstract
The content of low density lipoprotein (LDL) receptors in tissue from primary breast cancers was determined and its prognostic information compared with that of variables of established prognostic importance. Frozen tumour specimens were selected, and tissue from 72 patients (32 of whom had died) were studied. The LDL receptor content showed an inverse correlation with the survival time. Analysis by a multivariate statistical method showed that the presence of axillary metastasis, content of receptors for oestrogen and LDL, diameter of the tumour, and DNA pattern were all of prognostic value with regard to patient survival. Improved methods of predicting survival time in patients with breast cancer may be of value in the choice of treatment for individual patients.
摘要
测定原发性乳腺癌组织中低密度脂蛋白（LDL）受体的含量，并将其预后信息与已确定具有预后重要性的变量的预后信息进行比较。选择冷冻肿瘤标本，对72例患者（其中32例已死亡）的组织进行研究。LDL受体含量与生存时间呈负相关。多变量统计方法分析表明，腋窝转移的存在、雌激素和LDL受体的含量、肿瘤直径以及DNA模式对患者生存均具有预后价值。改进预测乳腺癌患者生存时间的方法可能对个体患者的治疗选择具有价值。
相似文献
1
Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.乳腺癌组织中低密度脂蛋白受体的含量与患者生存率的关系。
Br Med J (Clin Res Ed). 1986 Mar 1;292(6520):580-2. doi: 10.1136/bmj.292.6520.580.
2
[Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].[类固醇激素受体与乳腺癌腋窝淋巴结转移的关系]
Geburtshilfe Frauenheilkd. 1983 Dec;43(12):726-31. doi: 10.1055/s-2008-1036742.
3
Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.人类乳腺癌中可溶性和核雌激素受体状态与预后的关系
Br J Cancer. 1981 Jan;43(1):67-71. doi: 10.1038/bjc.1981.9.
4
The clinical application of oestrogen receptor analysis in early cancer of the breast.雌激素受体分析在早期乳腺癌中的临床应用。
Ann R Coll Surg Engl. 1982 May;64(3):165-70.
5
[Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].[原发性乳腺癌中的雄激素受体。与雌激素和孕激素受体相比，其与预后因素的关系]
Dtsch Med Wochenschr. 1988 Jun 3;113(22):892-7. doi: 10.1055/s-2008-1067739.
6
7
Prognostic value of estrogen receptor determinations in patients with breast cancer.
Cancer Res. 1978 Nov;38(11 Pt 2):4296-8.
8
[Correlation with mammography and estrogen receptors in breast neoplasms].
G Ital Oncol. 1990 Jan-Jun;10(1-2):41-6.
9
Prognostic factors in node-negative breast cancer patients: the experience in Taiwan.淋巴结阴性乳腺癌患者的预后因素：台湾地区的经验。
Changgeng Yi Xue Za Zhi. 1998 Dec;21(4):363-70.
10
[Prognostic value of receptor state determined by radiometric method in breast carcinoma].[放射测量法测定的受体状态在乳腺癌中的预后价值]
Pathologica. 1985 May-Jun;77(1049):315-21.
引用本文的文献
1
Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.将晚期内体胆固醇与癌症进展和抗癌药物耐药性联系起来。
Int J Mol Sci. 2022 Jun 29;23(13):7206. doi: 10.3390/ijms23137206.
2
Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits.脂质核心纳米粒携带的紫杉醇在晚期实体癌伴骨转移患者中的应用：缺乏毒性和治疗益处。
J Bone Oncol. 2022 Apr 20;34:100431. doi: 10.1016/j.jbo.2022.100431. eCollection 2022 Jun.
3
Statins: a repurposed drug to fight cancer.他汀类药物：一种用于抗癌的再利用药物。
J Exp Clin Cancer Res. 2021 Jul 24;40(1):241. doi: 10.1186/s13046-021-02041-2.
4
The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial.他汀类药物治疗对肿瘤内胆固醇水平和低密度脂蛋白受体表达的影响：一项乳腺癌机会性试验。
Cancer Metab. 2020 Nov 23;8(1):25. doi: 10.1186/s40170-020-00231-8.
5
Correlations between the metabolic profile and F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients.代谢谱与 F-FDG-正电子发射断层扫描-计算机断层扫描参数之间的相关性揭示了肺癌患者代谢重编程的复杂性。
Sci Rep. 2019 Nov 7;9(1):16212. doi: 10.1038/s41598-019-52667-8.
6
Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.负载多西他赛和沙利度胺的低密度脂蛋白修饰二氧化硅纳米颗粒用于肝癌的有效化疗
Braz J Med Biol Res. 2018 Jan 23;51(3):1-10. doi: 10.1590/1414-431X20176650.
7
Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.在高脂血症小鼠模型中，肿瘤低密度脂蛋白受体（LDLR）表达升高会加速低密度脂蛋白胆固醇介导的乳腺癌生长。
Oncogene. 2017 Nov 16;36(46):6462-6471. doi: 10.1038/onc.2017.247. Epub 2017 Jul 31.
8
Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.循环脂蛋白：引导鲨烯化药物进入低密度脂蛋白聚集癌细胞的特洛伊木马。
Mol Ther. 2017 Jul 5;25(7):1596-1605. doi: 10.1016/j.ymthe.2017.05.016. Epub 2017 Jun 9.
9
Insights into the Link Between Obesity and Cancer.肥胖与癌症之间联系的见解
Curr Obes Rep. 2017 Jun;6(2):195-203. doi: 10.1007/s13679-017-0263-x.
10
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.辛伐他汀增强了脂质纳米乳剂携带的紫杉醇对荷黑素瘤小鼠的抗肿瘤作用。
Int J Nanomedicine. 2016 Mar 7;11:885-904. doi: 10.2147/IJN.S88546. eCollection 2016.
本文引用的文献
1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Low-density lipoprotein metabolism in mice with soft tissue tumours.患有软组织肿瘤的小鼠的低密度脂蛋白代谢
Biochim Biophys Acta. 1984 Oct 4;795(3):589-95. doi: 10.1016/0005-2760(84)90189-9.
3
Proposal to decrease the risk and improve the prognosis of breast cancer.降低乳腺癌风险并改善预后的建议。
Am J Obstet Gynecol. 1984 Sep 15;150(2):119-32. doi: 10.1016/s0002-9378(84)80002-2.
4
5
Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway.通过低密度脂蛋白途径在体外将阿克拉霉素A递送至人胶质瘤细胞。
Cancer Res. 1983 Oct;43(10):4600-5.
6
Retinoic acid binding proteins and steroid receptor levels in human breast cancer.
Eur J Cancer Clin Oncol. 1982 Mar;18(3):221-6. doi: 10.1016/0277-5379(82)90040-2.
7
Targeted killing of cultured cells by receptor-dependent photosensitization.通过受体依赖性光致敏对培养细胞进行靶向杀伤。
Proc Natl Acad Sci U S A. 1981 Sep;78(9):5717-21. doi: 10.1073/pnas.78.9.5717.
8
Regulation of plasma cholesterol by lipoprotein receptors.脂蛋白受体对血浆胆固醇的调节。
Science. 1981 May 8;212(4495):628-35. doi: 10.1126/science.6261329.
9
DNA content and survival in mammary carcinoma.
Anal Quant Cytol. 1980 Sep;2(3):161-5.
10
Plasma lipids and mortality: a source of error.血浆脂质与死亡率：误差来源
Lancet. 1980 Mar 8;1(8167):523-6. doi: 10.1016/s0140-6736(80)92775-0.
Zotero 插件